< href=http://rxbuywithoutprescriptiononline.net/propecia.html>Propecia no prescription < href=http://rxbuywithoutprescriptiononline.org/lasix.html>lasix buy Sertraline online < href=http://rxnoprescriptionbuyonlinerx.net>Accutane without prescription buy trazodone online buy Zyban without prescription < href=http://rxbuyonlinewithoutprescription.net/zetia.html>zetia without prescription < href=http://rxbuywithoutprescriptiononline.net/clomid.html>Clomid Without Prescription < href=http://rxbuywithoutprescriptiononline.org/ventolin.html>buy ventolin < href=http://rxnoprescriptionbuyonline.com/strattera.html>buy Strattera < href=http://rxbuyonlinewithoutprescriptionrx.net/valtrex.html>buy Valtrex online < href=http://rxbuywithoutprescriptiononline.net/zithromax.html>buy Zithromax without prescription
portfolio

Prexton Therapeutics

Prexton Therapeutics has the mission to develop innovative drugs to improve the quality of life of people who suffer from Parkinson’s disease and other brain disorders. Prexton Therapeutics has the expertise to design novel mGluR4 compounds as new treatment for Parkinson’s disease.
 
 
CVRx
 

Details
Prexton Therapeutics
14 chemin des Aulx
1228 Plan les Ouates, Geneva
Switzerland
www.prextontherapeutics.com

 
Prexton Therapeutics news

16.03.18
Lundbeck to acquire Prexton Therapeutics adding foliglurax in clinical phase II to its pipeline of innovative treatments for patients suffering from Parkinson’s disease

10.07.17
Prexton announces initiation of phase II clinical testing in Parkinson’s disease

08.02.17
Prexton Therapeutics Series B financing round raises EUR 29 million (USD 31 million) to advance its novel Parkinson’s therapeutic

Read more
This website uses cookies to track its audience and improve its content. By continuing to browse this website, you agree to the use of such cookies. For more information on cookies check http://www.ysioscapital.com/legal-notice/ I agree